Curium announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
BEXLUTRY is the first radioligand equivalent for the treatment of GEP-NETs in adults and the first radioligand therapy from Curium approved by the FDABOSTON, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Admini
